Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Other Non-Current Liabilities of $3489.0 for Q1 2026, down 23.15% sequentially from $4540.0 in Q4 2025, and down 53.98% YoY from $7582.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Other Non-Current Liabilities for 6 years, with the latest figure at $3489.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 53.98% year-over-year to $3489.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3489.0 (down 53.98% YoY) and the FY2025 annual result came in at $4540.0, down 47.01% from the prior year.
- Other Non-Current Liabilities declined to $3489.0 in Q1 2026 per BJDX's latest filing, from $4540.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $15823.0 in Q4 2022 and troughed at $3489.0 in Q1 2026.
- A 5-year average of $10240.8 and a median of $10477.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Other Non-Current Liabilities fell 14.27% in 2023, then sank 53.98% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $15823.0 in 2022, then retreated by 22.13% to $12321.0 in 2023, then plunged by 30.47% to $8567.0 in 2024, then plunged by 47.01% to $4540.0 in 2025, then slipped by 23.15% to $3489.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3489.0, $4540.0, and $5573.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,419.00 |
| Mar 31, 2026 | 3,489.00 |
| Dec 31, 2025 | 4,540.00 |
| Sep 30, 2025 | 5,573.00 |
| Jun 30, 2025 | 6,589.00 |
| Mar 31, 2025 | 7,582.00 |
| Dec 31, 2024 | 8,567.00 |
| Sep 30, 2024 | 9,530.00 |
| Jun 30, 2024 | 10,477.00 |
| Mar 31, 2024 | 11,407.00 |
| Dec 31, 2023 | 12,321.00 |
| Sep 30, 2023 | 13,220.00 |
| Jun 30, 2023 | 14,104.00 |
| Mar 31, 2023 | 14,970.00 |
| Dec 31, 2022 | 15,823.00 |
| Sep 30, 2022 | 15,420.00 |
| Dec 31, 2020 | 155,629.00 |